Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine Plus Carboplatin in Metastatic TNBC
NCT03295552Phase 2Terminated
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Nov 2017
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in triple-negative breast cancer (TNBC), sponsored by Shanghai Jiao Tong University School of Medicine. Started Nov 2017; status: terminated.
02
Drugs
decitabine
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT03295552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03295552.